Found vs Trimi
Two GLP-1 providers, one scoreboard. We put Found and Trimi head-to-head on the published Brief Score — the same six factors, scored the same way.
The verdict
Trimi takes this head-to-head.
Trimi scores 89 to 81 on our six-factor Brief Score — A clean, all-in membership provider that publishes one price on both molecules nationwide and hasn't played the teaser-rate game.
That doesn't make Found a bad call — it's best for readers who want insurance run against their clinical visits and a clinician free to move them between compounded, brand and oral routes. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Found | Trimi | |
|---|---|---|
| Brief Score | 81/100 (B−) | 89/100 (B+) |
| Semaglutide | $289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); the advertised $99 is the in-network INSURANCE rate and still sits before a ~$30 per-visit copay | $175/mo month-to-month · $99/mo only on a 12-month prepay ($1,188 in one charge) |
| Tirzepatide | $289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); one program price covers both molecules | $235/mo month-to-month · $125/mo only on a 12-month prepay ($1,500 in one charge) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
| On the tracker | Stableprice stable | Stableprice stable |
Found: Headline unchanged, but our $129 line was wrong: the published floor is $99 and it requires a 3-, 6- or 12-month plan.
Trimi: Membership rate held flat this cycle — both molecules disclosed up front, no first-month teaser.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.